Multimedia

Dr Regueiro and Dr Huang, from the Cleveland Clinic, discuss the development of a novel disease model to identify targets for future ulcerative colitis therapeutic agents.

Dr Cohen, director of the IBD Center at the University of Chicago, recaps his presentation at the Crohn's & Colitis Congress 2021 on using novel small molecule agents to treat inflammatory bowel disease.

In this video, Dr Hanauer, from the Feinberg School of Medicine at Northwestern University in Chicago, reviews his presentation at the Crohn's & Colitis Congress 2021 on "evolutionary" agents on the horizon for treatment of inflammatory bowel...

In this video, Dr Abreu, director of the Crohn's and Colitis Center at the University of Miami Miller School of Medicine, previews her talk for the Crohn's & Colitis Congress 2021 on how basic research is being translated to advances in...

Dr Brenner discusses her presentation at the Crohn's & Colitis Congress on what data indicate about the risks and disease course of pediatric patients with inflammatory bowel disease during the COVID-19 pandemic.

Marla Dubinsky, MD, and Asher Kornbluth, MD, both from the Icahn School of Medicine at Mount Sinai in New York City, discuss the latest updates on COVID-19 vaccines, recent recommendations from the International Organization of Inflammatory...

Dr Long, professor of medicine at the University of North Carolina at Chapel Hill, discusses her presentation at the Advances in Inflammatory Bowel Disease 2020 virtual meeting on how data from both clinical trials and real-world practice...

Marla Dubinsky, MD, and Asher Kornbluth, MD, discuss their first-hand experience in treating patients with inflammatory bowel disease as New York City became one of the first hot spots for COVID-19, how they and their patients managed the...

In this video, Michael Chiorean, MD, reviews how JAK inhibitors, IL-12/23 inhibitors, and other, newer therapies are expanding the tools for management of ulcerative colitis.

Dr Kane, professor of medicine at the Mayo Clinic in Rochester, Minnesota, reviews her presentation at the AIBD 2020 virtual meeting on how best to inform and educate patients with inflammatory bowel disease to help ensure good outcomes.